MedLink Neurology Home

Your First Place To Look™ for authoritative, in-depth articles covering the full spectrum of neurology

Alerts

FDA approves oral treatment for spinal muscular atrophy
Aug 07, 2020
First drug for spinal muscular atrophy that can be taken orally, providing an important treatment option for patients with this disease.
CDC reports a novel strain of antibiotic-resistant meningitis
Jun 19, 2020
CDC issues new recommendation for treatment of deadly meningitis.

Resource Centers

Behavioral & Cognitive Disorders
Childhood Degenerative & Metabolic Disorders
Developmental Malformations
Epilepsy & Seizures
Headaches & Pain
Infectious Disorders
Miscellaneous Neurology Disorders
Miscellaneous Pediatric Neurology Disorders
Movement Disorders
Neuro-Oncology
Neuro-Ophthalmology & Neuro-Otology
Neuroimmunology
Neuromuscular Disorders
Peripheral Neuropathies
Sleep Disorders
Stroke & Vascular Disorders

Recently Updated Articles

Pathologic yawning: neurologic aspects
Whiplash injuries
Pregabalin
Multiple sclerosis and fertility
Drug-induced neurologic disorders

Site Overview - Key Features


Articles
1,200 continually-updated authoritative clinical reviews covering the entire spectrum of neurology.
Images and Videos
Nearly 3,000 illustrations, including video clips of neurologic disorders.
CME Information
Earn AMA PRA Category 1™ CME credits for routinely using MedLink Neurology.
Editorial Board
Distinguished Editorial Board and hundreds of expert authors.
External Resources
The world’s largest annotated directory of useful resources for neurologists.
Forum
Interact with your colleagues. Your privacy is protected.
Patient Handouts
Information for patients you can print or email when needed.
News
See what’s being published in the neurology and neuroscience literature.
Learn More

CME Accreditation

Accredited by the Accreditation Council for Continuing Medical Education
MedLink Corporation is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

MedLink Corporation designates each MedLink Neurology internet point-of-care activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. “AMA PRA Category 1 Credit” is a trademark of the American Medical Association.

Learn more and then earn CME credits.

Editorial Board

medlink neurology editor in chief raymond P roos MD Editor-In-Chief
Raymond P Roos MD, Editor-in-Chief, is the Marjorie and Robert E Straus Professor of Neurology at the University of Chicago and Associate Chair for Education for the Department of Neurology at University of Chicago Medical Center.

View the complete Editorial Board here.

Selected News

“Rare” brain disorder may not be so rare anymore, trends in Japan reveal
Oct 19, 2020
Scientists show that incidence and mortality of a rare brain disorder in Japan almost doubled from 2005 to 2014.
Investigational ALS drug prolongs patient survival in clinical trial
Oct 16, 2020
An experimental medication that was recently shown to slow the progression of amyotrophic lateral sclerosis has now demonstrated the potential to also prolong patient survival.
View All

Neurology Meetings

Neurology Meetings
A list of U.S. and international meetings, conferences, and symposiums of interest to neurologists.
Join MedLink Neurology

COVID-19 Neurologic Aspects

Neurological complications of coronavirus infections: knowns, unknowns, and who knows
Authors: Dr. Avindra Nath and Dr. Bryan Smith
COVID-19 and multiple sclerosis
Authors: Dr. Anthony Reder and Dr. Veronica P Cipriani

Learn More About MedLink Neurology


MedLink Neurology user tutorial
Earn CME credits